Clinical Chemistry, Malmö
1 – 10 of 1351
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Evaluation of a Particle Enhanced Turbidimetric Immunoassay (PETIA) for detecting calprotectin in sputum samples
(2026) In BMC Pulmonary Medicine
- Contribution to journal › Article
-
Mark
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma
- Contribution to journal › Article
- 2025
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
- Contribution to journal › Debate/Note/Editorial
-
Mark
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
- Contribution to journal › Article
-
Mark
Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer
- Contribution to journal › Article
-
Mark
Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing
- Contribution to journal › Article
-
Mark
Melanoma Proteomics Unveiled : Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
- Contribution to journal › Article
-
Mark
Acquired von Willebrand Syndrome : A Comprehensive Review and a Nordic Perspective
(2025) In Seminars in Thrombosis and Hemostasis
- Contribution to journal › Article
-
Mark
Increased ultra-large von Willebrand factor multimers in immune thrombocytopenia
- Contribution to journal › Article
-
Mark
Impact of KRAS mutation subtypes on morphological heterogeneity and immune landscape in surgically treated lung adenocarcinoma
- Contribution to journal › Article
